Home›Companies›Biotech & Pharma›TripleBar Bio

TripleBar Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 25, 2023·Suggest an edit

About TripleBar Bio

TripleBar Bio is a private company based in Emeryville, California, incorporated in 2019 in Delaware. It has reported $19,763,632 raised in one offering on Form D since October 2023. Its chief executive is Maria Cho.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 16, 2023Oct 25, 2023$19,763,632of $20.5M target9$2.1MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on TripleBar Bio's Form D filed Oct 25, 2023.

RW
Rose Wardle
Director
HL
Howard Levin
Director
DF
MC
Maria Cho
Chief Executive Officer and director

Sources

  1. SECTripleBar Bio, Inc. filing history